Aquinox Pharmaceuticals PE Ratio 2013-2018 | AQXP

Current and historical p/e ratio for Aquinox Pharmaceuticals (AQXP) from 2013 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aquinox Pharmaceuticals PE ratio as of March 21, 2019 is 0.00.
Aquinox Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-03-22 2.72 0.00
2018-12-31 2.16 $-1.14 0.00
2018-09-30 2.93 $-1.83 0.00
2018-06-30 2.65 $-1.69 0.00
2018-03-31 14.08 $-2.40 0.00
2017-12-31 11.76 $-2.14 0.00
2017-09-30 14.19 $-1.93 0.00
2017-06-30 14.07 $-1.89 0.00
2017-03-31 16.69 $-1.93 0.00
2016-12-31 16.51 $-1.96 0.00
2016-09-30 13.36 $-1.75 0.00
2016-06-30 6.62 $-1.72 0.00
2016-03-31 8.82 $-1.53 0.00
2015-12-31 12.48 $-1.74 0.00
2015-09-30 14.07 $-2.25 0.00
2015-06-30 6.94 $-2.41 0.00
2015-03-31 8.22 $-2.48 0.00
2014-12-31 7.50 $-3.16 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.066B $0.025B
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.066B 9.19
Teva Pharmaceutical Industries (TEVA) Israel $17.368B 5.99
Mylan (MYL) United Kingdom $15.092B 6.39
Bausch Health Cos (BHC) Canada $8.909B 6.34
Dr Reddy's Laboratories (RDY) India $6.693B 26.69
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.987B 3.23
Supernus Pharmaceuticals (SUPN) United States $1.977B 18.34
Homology Medicines (FIXX) United States $1.064B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.974B 90.48
CymaBay Therapeutics (CBAY) United States $0.768B 0.00
Voyager Therapeutics (VYGR) United States $0.612B 0.00
Assembly Biosciences (ASMB) United States $0.485B 0.00
Akorn (AKRX) United States $0.422B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.389B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.219B 0.00
Sol-Gel Technologies (SLGL) Israel $0.131B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.130B 0.00
Acasti Pharma (ACST) Canada $0.084B 0.00
Teligent (TLGT) United States $0.068B 0.00
Agile Therapeutics (AGRX) United States $0.067B 0.00
Evoke Pharma (EVOK) United States $0.026B 0.00
China Pharma Holdings (CPHI) China $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00